Marinus Pharms

MRNS NASDAQ
3.890
-0.060
-1.52%
盘后: 3.890 0 0.00% 17:04 07/19 EDT
开盘
3.950
昨收
3.950
最高
4.058
最低
3.860
成交量
38.63万
成交均量(3M)
50.13万
52周最高
10.54
52周最低
2.360
换手率
0.74%
市值
2.04亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Marinus Pharms MRNS股票价格,Marinus Pharms股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Marinus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on developing and commercializing therapeutics to treat epilepsy and neuropsychiatric disorders. Its clinical-stage product candidate, ganaxolone, is a modulator being developed in various dose forms, including intravenous, oral capsule and oral liquid, intended to provide more treatment options to adult and pediatric patient populations in both acute and chronic care settings. Ganaxolone acts on the GABAA receptor, a target in the brain known for both anti seizure and anti anxiety effects through positive allosteric modulation. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19 pediatric epilepsy.
展开 >

最近浏览

名称
价格
涨跌幅